Drug Accessibility

Analysts Lift Eli Lilly Price Targets as Medicare Expands Low‑Cost GLP‑1 Access

The upgrades reflect rising sales expectations after Medicare’s July 1 GLP‑1 Bridge widened affordable access and set a high bar ahead of Lilly’s August 5 earnings.